NBF2, an Algal Fiber-Rich Formula, Reverses Diabetic Dyslipidemia and Hyperglycemia In Vivo
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms251910828 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Nlandu Roger Ngatu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Public Health, Kagawa University Faculty of Medicine, Kagawa 761-0793, Japan. Hauptthemen laut MEDLINE: Hyperglycemia, Dyslipidemias, Diabetes Mellitus, Type 2. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: department of public health, Kagawa University Faculty of Medicine, Japan.
Abstract (Originalsprache)
Ulva prolifera, known as Aonori in Japan, is an edible alga species that is mass-cultivated in Japan. Supplementation with Aonori-derived biomaterials has been reported to enhance metabolic health in previous studies. This was an experimental study that evaluated the metabolic health effects of NBF2, a formula made of algal and junos Tanaka citrus-derived biomaterials, on obesity and type 2 diabetes (T2DM). We used 18 obese and hyperglycemic Otsuka Long-Evans Tokushima Fatty (OLETF) rats that were assigned randomly to three groups of six animals: a high-dose NBF2 drink (20 mg/kg) group, a low-dose (10 mg/kg) NBF2 drink group and the control group that received 2 mL of tap water daily for a total of six weeks. We also used eight LETO rats as the normal control group. In addition to the glucose tolerance test (OGTT), ELISA and real-time PCR assays were performed. High-dose and lowdose NBF2 improved insulin sensitivity, as well as glycemic and lipid profiles, as compared with control rats. The OGTT showed that both NBF2 groups and LETO rats had normalized glycemia by the 90-min time-point. NBF2 up-regulated PPARα/γ-mRNA and Sirt2-mRNA gene expressions in BAT and improved the blood pressure profile. These findings suggest that the NBF2 formula, which activates PPAR-α/γ mRNA and Sirt2-mRNA, may reverse dyslipidemia and hyperglycemia in T2DM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Public Health, Kagawa University Faculty of Medicine, Kagawa 761-0793, Japan.
- Department of Medical Pharmacology, Kagawa University Faculty of Medicine, Kagawa 761-0793, Japan.
- Department of Environmental Medicine, Kochi University School of Medicine, Nankoku 783-8505, Japan.
- Department of Anesthesiology, Kagawa University Faculty of Medicine, Kagawa 761-0793, Japan.
ORCID-Profile: Nlandu Roger Ngatu, Asadur Md Rahman, Kanae Kanda, Narufumi Suganuma, Tomohiro Hirao
Förderung
- department of public health, Kagawa University Faculty of Medicine, Japan
Zitieren
APA
Ngatu, N. R., Hossain, A., Maruo, N., Akumwami, S., Rahman, A. M., Eitoku, M., Kanda, K., Nishiyama, A., Suganuma, N., & Hirao, T. (2024). NBF2, an Algal Fiber-Rich Formula, Reverses Diabetic Dyslipidemia and Hyperglycemia In Vivo. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms251910828
Vancouver
Ngatu NR, Hossain A, Maruo N, Akumwami S, Rahman AM, Eitoku M, et al. NBF2, an Algal Fiber-Rich Formula, Reverses Diabetic Dyslipidemia and Hyperglycemia In Vivo. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms251910828
BibTeX
@article{Ngatu2024,
author = {Ngatu, Nlandu Roger and Hossain, Akram and Maruo, Nao and Akumwami, Steeve and Rahman, Asadur Md and Eitoku, Masamitsu and Kanda, Kanae and Nishiyama, Akira and Suganuma, Narufumi and Hirao, Tomohiro},
title = {NBF2, an Algal Fiber-Rich Formula, Reverses Diabetic Dyslipidemia and Hyperglycemia In Vivo},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms251910828}
}
EUVIMED